Skip to main content

Merck & Co., Inc.

corporate_fare Company Profile

Merck & Co., Inc.

MRK·NYSE·Life Sciences·CIK 0000310158

Merck & Co., Inc. is a global healthcare company providing innovative health solutions through prescription medicines, including biologic therapies, vaccines, and animal health products. The company manages its operations primarily on a product basis, with two reportable operating segments: Pharmaceutical and Animal Health. The Pharmaceutical segment encompasses human health pharmaceutical and vaccine products. Human health pharmaceutical products are therapeutic and preventive agents, generally sold by prescription, for treating human disorders. Merck sells these products mainly to drug wholesalers and retailers, hospitals, government agencies, and managed healthcare providers like health maintenance organizations and pharmacy benefit managers. Human health vaccine products include preventive pediatric, adolescent, and adult vaccines, sold primarily to physicians, wholesalers, distributors, and government entities. The Animal Health segment focuses on discovering, developing, manufacturing, and marketing a broad range of veterinary pharmaceutical and vaccine products, alongside health management solutions and services. These offerings aim to prevent, treat, and control diseases in all major livestock and companion animal species. This segment also provides a comprehensive suite of digitally connected identification, traceability, and monitoring products. Merck sells its animal health products to veterinarians, distributors, animal producers, farmers, and pet owners.

Merck & Co., Inc. (NYSE:MRK) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 53 items for MRK at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-08, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for MRK spans 10-Q, 8-K.

Recent high-impact activity:

  • Inhibrx's INBRX-106 + Keytruda Nearly Doubles Response Rate in Head and Neck Cancer
  • Novartis Inks $3.2B Deal for Alteogen's Drug Delivery Tech Used in Merck's Keytruda
  • Senators Question Health Secretary Kennedy on Gardasil Settlement Disclosures
  • Merck's mRNA Melanoma Vaccine Cuts Recurrence in Late-Stage Trial
  • Merck-Moderna mRNA Cancer Therapy Hits Phase 3 Endpoints in Melanoma

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$65.01B
Net Income
$18.25B
Diluted EPS
$7.28
Op. Cash Flow
$16.47B
Free Cash Flow
$12.36B
Gross Profit
$48.63B
Cash & Equivalents
$14.56B
Total Debt
$49.05B
Debt / Equity
0.93×
Net Margin
28.1%
Shares Outstanding
2.5B sh
Source: 10-K · filed 2026-02-24 · accession 0000310158-26-000063

Dilution Risk

Low risk

Filing-implied dilution signals for MRK, detected from its recent SEC filings · based on capital-structure filings through 2026-05-20.

1 recent capital raise

Debt Offering Finalized · Refinancing Acquisition Debt

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with M →
$144.01 +0.08% today
52-week range · as of 2026-08-07 $77.58 – $144.01
Market cap
$355.1B
Volume
8.7M (0.8× avg)
3-mo avg 10.3M
Live data · 2026-09-13 20:43 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MRK - Latest Insights

MRK
Sep 08, 2026, 11:29 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $148.81
Real-time Price: $144.01 info
Change: -$4.80 (-3%) info
Market Cap: $355.1B info
MRK
Sep 02, 2026, 8:09 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $150.01
Real-time Price: $144.01 info
Change: -$6.00 (-4%) info
Market Cap: $355.1B info
MRK
Aug 25, 2026, 5:00 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $151.31
Real-time Price: $144.01 info
Change: -$7.30 (-5%) info
Market Cap: $355.1B info
MRK
Aug 24, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $153.16
Real-time Price: $144.01 info
Change: -$9.15 (-6%) info
Market Cap: $355.1B info
MRK
Aug 19, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $135.24
Real-time Price: $144.01 info
Change: +$8.77 (+6%) info
Market Cap: $355.1B info
MRK
Aug 07, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $128.63
Real-time Price: $144.01 info
Change: +$15.38 (+12%) info
Market Cap: $355.1B info
MRK
Aug 05, 2026, 11:04 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $130.72
Real-time Price: $144.01 info
Change: +$13.29 (+10%) info
Market Cap: $355.1B info
MRK
Aug 05, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $128.72
Real-time Price: $144.01 info
Change: +$15.29 (+12%) info
Market Cap: $355.1B info
MRK
Aug 04, 2026, 2:26 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $128.71
Real-time Price: $144.01 info
Change: +$15.30 (+12%) info
Market Cap: $355.1B info
MRK
Aug 04, 2026, 6:47 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $130.00
Real-time Price: $144.01 info
Change: +$14.01 (+11%) info
Market Cap: $355.1B info
MRK
Aug 04, 2026, 6:30 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $126.81
Real-time Price: $144.01 info
Change: +$17.20 (+14%) info
Market Cap: $355.1B info
MRK
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $131.67
Real-time Price: $144.01 info
Change: +$12.34 (+9%) info
Market Cap: $355.1B info
MRK
Jul 30, 2026, 1:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $129.20
Real-time Price: $144.01 info
Change: +$14.81 (+11%) info
Market Cap: $355.1B info
MRK
Jul 30, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $129.50
Real-time Price: $144.01 info
Change: +$14.51 (+11%) info
Market Cap: $355.1B info
MRK
Jul 24, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $127.99
Real-time Price: $144.01 info
Change: +$16.02 (+13%) info
Market Cap: $355.1B info
MRK
Jul 16, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $124.10
Real-time Price: $144.01 info
Change: +$19.91 (+16%) info
Market Cap: $355.1B info
MRK
Jul 10, 2026, 10:28 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $124.47
Real-time Price: $144.01 info
Change: +$19.54 (+16%) info
Market Cap: $355.1B info
MRK
Jul 06, 2026, 7:19 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $130.08
Real-time Price: $144.01 info
Change: +$13.93 (+11%) info
Market Cap: $355.1B info
MRK
Jun 22, 2026, 6:49 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $113.86
Real-time Price: $144.01 info
Change: +$30.15 (+26%) info
Market Cap: $355.1B info
MRK
Jun 18, 2026, 6:45 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $115.49
Real-time Price: $144.01 info
Change: +$28.52 (+25%) info
Market Cap: $355.1B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets